9.2 What are the outputs that will be measured? The outputs that will be measured are the spread of PFB implementation for the duration of the outpatients programme (to March 2006), hospital cancellation rates and 'did not attend' rates. Patient satisfaction has also been determined through a survey of patients in Dermatology clinics throughout Scotland in 2005. Sites are measuring DNA rates, cancellation rates and waiting times. Audit Scotland calculate DNA rate of 1 in 7 (14%) DNAs cost £20m per annum (Audit Scotland 2003) PFB should reduce DNA rates to 5% or less Audit Scotland calculate that there is a total of 10 million OP attendances. Acute Hospitals see 6.5 million patients; 31% of appointments are first appointments All Acute Hospitals are implementing PFB for first appointments (6.5/10 of £20m) (£13m x 31%) (9/14 improvement of £4.03m) This gives a time releasing saving of £2.59m on Did Not Attends. National definitions and metrics do not yet exist for hospital cancellations and so no value is yet attributed to these expected improvements. However, Audit Scotland estimated that 1% of clinics are cancelled which may be as many as 100,000 appointments of which 65,000 would be in hospitals. Where possible, PFB utilises existing data reporting systems e.g. MMI data, which is reported to the National Waiting Times Unit. Due to the requirement for timely reporting, this data is not fully validated. In addition to the above, due to the poor nature of some of the outpatients data currently collected and the fact that data on patients seen by anyone other than a consultant not yet collected there are some risks to collection and accuracy. Quantitative data is collected monthly, where possible, using existing data reporting processes e.g. MMI (monthly management information) data. Qualitative data (in the form of staff and patient satisfaction surveys) is collected locally and fed into Centre for Change and Innovation ( CCI). |